Test Code ALBSF Albumin, Spinal Fluid
Ordering Guidance
The SFIG / Cerebrospinal Fluid IgG Index Profile, Serum and Spinal Fluid, in conjunction with OLIG / Oligoclonal Banding, Serum and Spinal Fluid is the recommended test for evaluation of multiple sclerosis.
Specimen Required
Specimen Type: Spinal fluid
Container/Tube: Sterile vial
Specimen Volume: 1 mL
Collection Instructions: Label specimen as spinal fluid.
Secondary ID
68001Useful For
Assessment of blood-brain barrier permeability
Highlights
This test enables quantification of albumin concentration in spinal fluid by nephelometry. A standalone spinal fluid albumin concentration has limited clinical utility; it may provide a general assessment of intactness of the blood-brain barrier.
Method Name
Nephelometry
Reporting Name
Albumin, CSFSpecimen Type
CSFSpecimen Minimum Volume
0.5 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
CSF | Refrigerated (preferred) | 28 days | |
Frozen | 28 days | ||
Ambient | 14 days |
Reject Due To
Gross hemolysis | OK |
Clinical Information
Elevated albumin concentration in spinal fluid may serve as an indicator of the permeability status of the blood-brain barrier. Comparison to an ALB / Albumin, Serum concentration is recommended.
Reference Values
0.0-27.0 mg/dL
Interpretation
Elevated albumin concentrations may be observed in patients with a compromised blood-brain barrier.
Method Description
The cerebrospinal fluid albumin is determined by immunonephelometry on a Siemens Nephelometer II. In this assay, the light scattered onto the antigen-antibody complexes is measured. The intensity of the measured scattered light is proportional to the amount of antigen-antibody complexes in the sample under certain conditions. If the antibody volume is kept constant, the signal behaves proportionally to the antigen volume. A reference curve is generated by a standard with a known antigen content on which the scattered light signals of the samples can be evaluated and calculated as an antigen concentration. Antigen-antibody complexes are formed when a sample containing antigen and the corresponding antiserum are put into a cuvette. A light beam is generated with a light emitting diode, which is transmitted through the cuvette. The light is scattered onto the immuno-complexes that are present. Antigen and antibody are mixed in the initial measurement, but no complex is yet formed. An antigen-antibody complex is formed in the final measurement. The result is calculated by subtracting the value of the final measurement from the initial measurement. The distribution of intensity of the scattered light depends on the ratio of the particle size of the antigen-antibody complexes to the radiated wavelength.(Instruction manual: Siemens Nephelometer II. Siemens, Inc; Version 2.3, 2008; Addendum to the Instruction Manual 2.3, 08/2017)
Day(s) Performed
Monday through Friday
Performing Laboratory
Mayo Clinic Laboratories in RochesterTest Classification
This test has been cleared, approved, or is exempt by the US Food and Drug Administration and is used per manufacturer's instructions. Performance characteristics were verified by Mayo Clinic in a manner consistent with CLIA requirements.CPT Code Information
82042
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
ALBSF | Albumin, CSF | 1746-7 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
ALBSF | Albumin, CSF | 1746-7 |